TREA

90765924 - CYCART

Follow

Information

  • Trademark
  • 90765924
  • Serial Number
    90765924
  • Filing Date
    June 10, 2021
    3 years ago
  • Transaction Date
    August 18, 2023
    a year ago
  • Status Date
    June 15, 2023
    a year ago
  • Location Date
    June 15, 2023
    a year ago
  • First Use Anywhere Date
    January 07, 2020
    5 years ago
  • First Use In Commerce Date
    June 02, 2021
    3 years ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED
    Employee Name
    HUSSAIN, TASNEEM
  • Attorney Docket Number
    CLTY-2122US/
    Attorney Name
    CAMILLE M. MILLER
    Law Office Assigned Location Code
    M90
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
CYCART
Case File Statements
  • GS0051: Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, placental-derived cells, umbilical cord cells, placental-derived T cells, chimeric antigen receptor (CAR) T cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering and burn dressing; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds and burns; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
  • GS0011: Bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; placental-derived cells, chimeric antigen receptor (CAR) T cells, and placental-derived T cells with a chimeric antigen receptor (CAR), all for use in scientific, laboratory and medical research
Case File Event Statements
  • 8/18/2023 - a year ago
    30 - EXPARTE APPEAL TERMINATED Type: EXPT
  • 8/18/2023 - a year ago
    29 - EXPARTE APPEAL DISMISSED AS MOOT Type: EXDM
  • 6/15/2023 - a year ago
    28 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 6/15/2023 - a year ago
    27 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 6/15/2023 - a year ago
    26 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 5/31/2023 - a year ago
    25 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/14/2023 - a year ago
    24 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/14/2023 - a year ago
    23 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/14/2023 - a year ago
    22 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/16/2022 - 2 years ago
    21 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 12/16/2022 - 2 years ago
    20 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 12/16/2022 - 2 years ago
    19 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 12/16/2022 - 2 years ago
    18 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 6/16/2022 - 2 years ago
    17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 6/16/2022 - 2 years ago
    16 - FINAL REFUSAL E-MAILED Type: GNFR
  • 6/16/2022 - 2 years ago
    15 - FINAL REFUSAL WRITTEN Type: CNFR
  • 4/13/2022 - 2 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/12/2022 - 2 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/12/2022 - 2 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/9/2022 - 2 years ago
    11 - NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Type: AAUA
  • 3/8/2022 - 2 years ago
    10 - USE AMENDMENT ACCEPTED Type: IUAA
  • 3/8/2022 - 2 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/8/2022 - 2 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/8/2022 - 2 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/1/2022 - 2 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/2/2021 - 3 years ago
    5 - AMENDMENT TO USE PROCESSING COMPLETE Type: AUPC
  • 9/2/2021 - 3 years ago
    4 - USE AMENDMENT FILED Type: IUAF
  • 6/15/2021 - 3 years ago
    3 - TEAS AMENDMENT OF USE RECEIVED Type: EAAU
  • 8/30/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/14/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP